193 related articles for article (PubMed ID: 21979893)
1. Novel amplifications in pediatric medulloblastoma identified by genome-wide copy number profiling.
Nord H; Pfeifer S; Nilsson P; Sandgren J; Popova S; Strömberg B; Alafuzoff I; Nistér M; Díaz de Ståhl T
J Neurooncol; 2012 Mar; 107(1):37-49. PubMed ID: 21979893
[TBL] [Abstract][Full Text] [Related]
2. Genome wide copy number abnormalities in pediatric medulloblastomas as assessed by array comparative genome hybridization.
Lo KC; Rossi MR; Eberhart CG; Cowell JK
Brain Pathol; 2007 Jul; 17(3):282-96. PubMed ID: 17465989
[TBL] [Abstract][Full Text] [Related]
3. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
[TBL] [Abstract][Full Text] [Related]
4. Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification.
Korshunov A; Remke M; Werft W; Benner A; Ryzhova M; Witt H; Sturm D; Wittmann A; Schöttler A; Felsberg J; Reifenberger G; Rutkowski S; Scheurlen W; Kulozik AE; von Deimling A; Lichter P; Pfister SM
J Clin Oncol; 2010 Jun; 28(18):3054-60. PubMed ID: 20479417
[TBL] [Abstract][Full Text] [Related]
5. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
[TBL] [Abstract][Full Text] [Related]
6. Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medulloblastomas.
Lo KC; Rossi MR; Burkhardt T; Pomeroy SL; Cowell JK
Genes Chromosomes Cancer; 2007 Jan; 46(1):53-66. PubMed ID: 17044047
[TBL] [Abstract][Full Text] [Related]
7. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma.
Langdon JA; Lamont JM; Scott DK; Dyer S; Prebble E; Bown N; Grundy RG; Ellison DW; Clifford SC
Genes Chromosomes Cancer; 2006 Jan; 45(1):47-60. PubMed ID: 16149064
[TBL] [Abstract][Full Text] [Related]
8. Biological and clinical heterogeneity of MYCN-amplified medulloblastoma.
Korshunov A; Remke M; Kool M; Hielscher T; Northcott PA; Williamson D; Pfaff E; Witt H; Jones DT; Ryzhova M; Cho YJ; Wittmann A; Benner A; Weiss WA; von Deimling A; Scheurlen W; Kulozik AE; Clifford SC; Peter Collins V; Westermann F; Taylor MD; Lichter P; Pfister SM
Acta Neuropathol; 2012 Apr; 123(4):515-27. PubMed ID: 22160402
[TBL] [Abstract][Full Text] [Related]
9. Characterization of novel and complex genomic aberrations in glioblastoma using a 32K BAC array.
Nord H; Hartmann C; Andersson R; Menzel U; Pfeifer S; Piotrowski A; Bogdan A; Kloc W; Sandgren J; Olofsson T; Hesselager G; Blomquist E; Komorowski J; von Deimling A; Bruder CE; Dumanski JP; Díaz de Ståhl T
Neuro Oncol; 2009 Dec; 11(6):803-18. PubMed ID: 19304958
[TBL] [Abstract][Full Text] [Related]
10. Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
Zitterbart K; Filkova H; Tomasikova L; Necesalova E; Zambo I; Kantorova D; Slamova I; Vranova V; Zezulkova D; Pesakova M; Pavelka Z; Veselska R; Kuglik P; Sterba J
J Neurooncol; 2011 Mar; 102(1):25-33. PubMed ID: 20607354
[TBL] [Abstract][Full Text] [Related]
11. Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.
Goschzik T; Schwalbe EC; Hicks D; Smith A; Zur Muehlen A; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Clifford SC
Lancet Oncol; 2018 Dec; 19(12):1602-1616. PubMed ID: 30392813
[TBL] [Abstract][Full Text] [Related]
12. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive high-resolution genomic profiling and cytogenetics of two pediatric and one adult medulloblastoma.
Holland H; Xu LX; Ahnert P; Kirsten H; Koschny R; Bauer M; Schober R; Meixensberger J; Krupp W
Pathol Res Pract; 2013 Sep; 209(9):541-7. PubMed ID: 23896263
[TBL] [Abstract][Full Text] [Related]
14. Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization.
Michiels EM; Weiss MM; Hoovers JM; Baak JP; Voûte PA; Baas F; Hermsen MA
J Pediatr Hematol Oncol; 2002; 24(3):205-10. PubMed ID: 11990307
[TBL] [Abstract][Full Text] [Related]
15. Metaphase and array comparative genomic hybridization: unique copy number changes and gene amplification of medulloblastomas in South America.
Yoshimoto M; Bayani J; Nuin PA; Silva NS; Cavalheiro S; Stavale JN; Andrade JA; Zielenska M; Squire JA; de Toledo SR
Cancer Genet Cytogenet; 2006 Oct; 170(1):40-7. PubMed ID: 16965953
[TBL] [Abstract][Full Text] [Related]
16. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma.
Mendrzyk F; Radlwimmer B; Joos S; Kokocinski F; Benner A; Stange DE; Neben K; Fiegler H; Carter NP; Reifenberger G; Korshunov A; Lichter P
J Clin Oncol; 2005 Dec; 23(34):8853-62. PubMed ID: 16314645
[TBL] [Abstract][Full Text] [Related]
17. Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma.
McCabe MG; Bäcklund LM; Leong HS; Ichimura K; Collins VP
Neuro Oncol; 2011 Apr; 13(4):376-83. PubMed ID: 21292688
[TBL] [Abstract][Full Text] [Related]
18. Medulloblastoma outcome is adversely associated with overexpression of EEF1D, RPL30, and RPS20 on the long arm of chromosome 8.
De Bortoli M; Castellino RC; Lu XY; Deyo J; Sturla LM; Adesina AM; Perlaky L; Pomeroy SL; Lau CC; Man TK; Rao PH; Kim JY
BMC Cancer; 2006 Sep; 6():223. PubMed ID: 16968546
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations in pediatric medulloblastomas detected by comparative genomic hybridization.
Nishizaki T; Harada K; Kubota H; Ozaki S; Ito H; Sasaki K
Pediatr Neurosurg; 1999 Jul; 31(1):27-32. PubMed ID: 10545819
[TBL] [Abstract][Full Text] [Related]
20. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Kool M; Koster J; Bunt J; Hasselt NE; Lakeman A; van Sluis P; Troost D; Meeteren NS; Caron HN; Cloos J; Mrsić A; Ylstra B; Grajkowska W; Hartmann W; Pietsch T; Ellison D; Clifford SC; Versteeg R
PLoS One; 2008 Aug; 3(8):e3088. PubMed ID: 18769486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]